Johnson & Johnson returns to New Jersey the week of intensive D.C. lobbying on drug prices

Johnson & Johnson flew from Hope, Arkansas to Trenton, New Jersey on May 22, 2026, a routine repositioning flight that brings a Gulfstream G650ER back to the company's home base. The 6-hour, 13-minute trip from a small Arkansas airport to KTTN near New Brunswick arrives without a headline event at the destination — but the context is the weeks-long lobbying campaign by the pharmaceutical giant.

The flight lands the same period that Johnson & Johnson's fleet of four jets has been making repeated trips into Washington, D.C., as reported by Endpoints News. The outlet documented more than 120 arrivals by top drugmakers' planes at D.C.-area airports through September 2025, including multiple visits by Johnson & Johnson aircraft. The pattern has intensified as the Trump administration pushes for lower drug prices and demands that companies match foreign pricing.

Recent flight records show Johnson & Johnson's jets shuttling between its New Jersey headquarters and the capital at least three times in May alone — consistent with the company's heavy lobbying presence. This return flight from Hope, Arkansas, likely a visit to a regional facility, underscores the hectic travel schedule of a firm that spends billions on both R&D and Washington influence.